Literature DB >> 21880467

Purines and neuronal excitability: links to the ketogenic diet.

S A Masino1, M Kawamura, D N Ruskin, J D Geiger, D Boison.   

Abstract

ATP and adenosine are purines that play dual roles in cell metabolism and neuronal signaling. Acting at the A(1) receptor (A(1)R) subtype, adenosine acts directly on neurons to inhibit excitability and is a powerful endogenous neuroprotective and anticonvulsant molecule. Previous research showed an increase in ATP and other cell energy parameters when an animal is administered a ketogenic diet, an established metabolic therapy to reduce epileptic seizures, but the relationship among purines, neuronal excitability and the ketogenic diet was unclear. Recent work in vivo and in vitro tested the specific hypothesis that adenosine acting at A(1)Rs is a key mechanism underlying the success of ketogenic diet therapy and yielded direct evidence linking A(1)Rs to the antiepileptic effects of a ketogenic diet. Specifically, an in vitro mimic of a ketogenic diet revealed an A(1)R-dependent metabolic autocrine hyperpolarization of hippocampal neurons. In parallel, applying the ketogenic diet in vivo to transgenic mouse models with spontaneous electrographic seizures revealed that intact A(1)Rs are necessary for the seizure-suppressing effects of the diet. This is the first direct in vivo evidence linking A(1)Rs to the antiepileptic effects of a ketogenic diet. Other predictions of the relationship between purines and the ketogenic diet are discussed. Taken together, recent research on the role of purines may offer new opportunities for metabolic therapy and insight into its underlying mechanisms.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880467      PMCID: PMC3242925          DOI: 10.1016/j.eplepsyres.2011.07.014

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  95 in total

1.  Temperature-dependent modulation of excitatory transmission in hippocampal slices is mediated by extracellular adenosine.

Authors:  S A Masino; T V Dunwiddie
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

2.  A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.

Authors:  Jessica L Koranda; David N Ruskin; Susan A Masino; J Harry Blaise
Journal:  J Neurophysiol       Date:  2011-05-25       Impact factor: 2.714

3.  The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

Authors:  David Tendler; Sauyu Lin; William S Yancy; John Mavropoulos; Pam Sylvestre; Don C Rockey; Eric C Westman
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

4.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Authors:  B Johansson; L Halldner; T V Dunwiddie; S A Masino; W Poelchen; L Giménez-Llort; R M Escorihuela; A Fernández-Teruel; Z Wiesenfeld-Hallin; X J Xu; A Hårdemark; C Betsholtz; E Herlenius; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

5.  A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.

Authors:  David N Ruskin; Jessica L Ross; Masahito Kawamura; Tiffany L Ruiz; Jonathan D Geiger; Susan A Masino
Journal:  Physiol Behav       Date:  2011-04-09

6.  ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.

Authors:  M F Jarvis; H Yu; K Kohlhaas; K Alexander; C H Lee; M Jiang; S S Bhagwat; M Williams; E A Kowaluk
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

7.  The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively.

Authors:  C Hemingway; J M Freeman; D J Pillas; P L Pyzik
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

8.  Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture.

Authors:  Nanna Goldman; Michael Chen; Takumi Fujita; Qiwu Xu; Weiguo Peng; Wei Liu; Tina K Jensen; Yong Pei; Fushun Wang; Xiaoning Han; Jiang-Fan Chen; Jurgen Schnermann; Takahiro Takano; Lane Bekar; Kim Tieu; Maiken Nedergaard
Journal:  Nat Neurosci       Date:  2010-05-30       Impact factor: 24.884

9.  Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition.

Authors:  L Massieu; M L Haces; T Montiel; K Hernández-Fonseca
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Polyunsaturated fatty acids and cerebrospinal fluid from children on the ketogenic diet open a voltage-gated K channel: a putative mechanism of antiseizure action.

Authors:  Xiang-ping Xu; Daniel Erichsen; Sara I Börjesson; Maria Dahlin; Per Amark; Fredrik Elinder
Journal:  Epilepsy Res       Date:  2008-05-02       Impact factor: 3.045

View more
  16 in total

Review 1.  The role of adenosine in epilepsy.

Authors:  Landen Weltha; Jesica Reemmer; Detlev Boison
Journal:  Brain Res Bull       Date:  2018-11-20       Impact factor: 4.077

Review 2.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

Review 3.  Adenosine dysfunction in epilepsy.

Authors:  Detlev Boison
Journal:  Glia       Date:  2011-12-22       Impact factor: 7.452

4.  Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.

Authors:  Maria José Diógenes; Raquel Neves-Tomé; Sergio Fucile; Katiuscia Martinello; Maria Scianni; Panos Theofilas; Jan Lopatár; Joaquim A Ribeiro; Laura Maggi; Bruno G Frenguelli; Cristina Limatola; Detlev Boison; Ana M Sebastião
Journal:  Cereb Cortex       Date:  2012-09-20       Impact factor: 5.357

Review 5.  Adenosine kinase: exploitation for therapeutic gain.

Authors:  Detlev Boison
Journal:  Pharmacol Rev       Date:  2013-04-16       Impact factor: 25.468

Review 6.  Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet.

Authors:  Michael A Rogawski; Wolfgang Löscher; Jong M Rho
Journal:  Cold Spring Harb Perspect Med       Date:  2016-05-02       Impact factor: 6.915

Review 7.  Adenosinergic signaling in epilepsy.

Authors:  Detlev Boison
Journal:  Neuropharmacology       Date:  2015-09-01       Impact factor: 5.250

Review 8.  Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Authors:  Joeri Van Liefferinge; Ann Massie; Jeanelle Portelli; Giuseppe Di Giovanni; Ilse Smolders
Journal:  Front Cell Neurosci       Date:  2013-08-30       Impact factor: 5.505

9.  Deep sequencing reveals increased DNA methylation in chronic rat epilepsy.

Authors:  Katja Kobow; Antony Kaspi; K N Harikrishnan; Katharina Kiese; Mark Ziemann; Ishant Khurana; Ina Fritzsche; Jan Hauke; Eric Hahnen; Roland Coras; Angelika Mühlebner; Assam El-Osta; Ingmar Blümcke
Journal:  Acta Neuropathol       Date:  2013-09-05       Impact factor: 17.088

Review 10.  Role of Adenosine in Epilepsy and Seizures.

Authors:  Fabio C Tescarollo; Diogo M Rombo; Lindsay K DeLiberto; Denise E Fedele; Enmar Alharfoush; Ângelo R Tomé; Rodrigo A Cunha; Ana M Sebastião; Detlev Boison
Journal:  J Caffeine Adenosine Res       Date:  2020-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.